Literature DB >> 11423668

The oncologic four-minute mile.

B A Chabner.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11423668

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


× No keyword cloud information.
  5 in total

1.  Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy.

Authors:  Jan Trøst Jørgensen
Journal:  Oncologist       Date:  2019-04-02

2.  Approval after phase I: ceritinib runs the three-minute mile.

Authors:  Bruce A Chabner
Journal:  Oncologist       Date:  2014-05-01

Review 3.  Innovation in Oncology Drug Development.

Authors:  Matthew Huber; Brian Huber
Journal:  J Oncol       Date:  2019-11-23       Impact factor: 4.375

4.  Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.

Authors:  Cuiping Pan; Jesper V Olsen; Henrik Daub; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2009-08-03       Impact factor: 5.911

Review 5.  Sufficiency of Single-Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib.

Authors:  P Selaru; Y Tang; B Huang; A Polli; K D Wilner; E Donnelly; D P Cohen
Journal:  Clin Transl Sci       Date:  2016-03-01       Impact factor: 4.689

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.